The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo
Abstract
Development of a cell therapy for diabetes would be greatly aided by a renewable supply of human beta-cells. Here we show that pancreatic endoderm derived from human embryonic stem (hES) cells efficiently generates glucose-responsive endocrine cells after implantation into mice. Upon glucose stimulation of the implanted mice, human insulin and C-peptide are detected in sera at levels similar to those of mice transplanted with approximately 3,000 human islets. Moreover, the insulin-expressing cells generated after engraftment exhibit many properties of functional beta-cells, including expression of critical beta-cell transcription factors, appropriate processing of proinsulin and the presence of mature endocrine secretory granules. Finally, in a test of therapeutic potential, we demonstrate that implantation of hES cell-derived pancreatic endoderm protects against streptozotocin-induced hyperglycemia. Together, these data provide definitive evidence that hES cells are competent to generate glucose-responsive, insulin-secreting cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, ViaCyte developed a stem cell-derived pancreatic endoderm cell population known as PEC-01, which they demonstrated to mature over several months in vivo into insulin-producing endocrine cells in rodent models.29–31”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [31]
Citations
Cites
Brissova, M., Fowler, M. J., Nicholson, W. E., Chu, A., Hirshberg, B., Harlan, D. M., & Powers, A. C. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5c6684.2005 · Cited by 797
Successful Islet Transplantation
Ryan, E. A., Lakey, J. R. T., Paty, B. W., Imes, S., Korbutt, G. S., Kneteman, N. M., Bigam, D., Rajotte, R. V., & Shapiro, A. M. J. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2148 · Cited by 719
Flagged first, then by citations
Research works printed but not linked: 43
- Lakey, J.R., Mirbolooki, M. & Shapiro, A.M. Current status of clinical islet cell transplantation. Methods Mol. Biol. 333, 47–104 (2006).
- Amit, M. et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271–278 (2000). · DOI
- Rosler, E.S. et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev. Dyn. 229, 259–274 (2004). · DOI
- D'Amour, K.A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534–1541 (2005). · DOI · Paper page
- D'Amour, K.A. et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392–1401 (2006). · DOI
- Jiang, J. et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25, 1940–1953 (2007). · DOI
- Tuch, B.E., Osgerby, K.J. & Turtle, J.R. Reversal of diabetes in hyperglycaemic nude mice by human fetal pancreas. Transplant. Proc. 21, 2665–2666 (1989).
- Beattie, G.M., Butler, C. & Hayek, A. Morphology and function of cultured human fetal pancreatic cells transplanted into athymic mice: a longitudinal study. Cell Transplant. 3, 421–425 (1994). · DOI
- Hayek, A. & Beattie, G.M. Experimental transplantation of human fetal and adult pancreatic islets. J. Clin. Endocrinol. Metab. 82, 2471–2475 (1997).
- Castaing, M. et al. Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice. Diabetologia 44, 2066–2076 (2001). · DOI
- Castaing, M., Duvillie, B., Quemeneur, E., Basmaciogullari, A. & Scharfmann, R. Ex vivo analysis of acinar and endocrine cell development in the human embryonic pancreas. Dev. Dyn. 234, 339–345 (2005). · DOI
- Jensen, J. Gene regulatory factors in pancreatic development. Dev. Dyn. 229, 176–200 (2004). · DOI
- Zorn, A.M. & Wells, J.M. Molecular basis of vertebrate endoderm development. Int. Rev. Cytol. 259, 49–111 (2007). · DOI
- Jorgensen, M.C. et al. An illustrated review of early pancreas development in the mouse. Endocr. Rev. 28, 685–705 (2007). · DOI
- Gaber, A.O. et al. Human islet graft function in NOD-SCID mice predicts clinical response in islet transplant recipients. Transplant. Proc. 36, 1108–1110 (2004). · DOI
- Cabrera, O. et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. USA 103, 2334–2339 (2006). · DOI · Paper page
- Guz, Y. et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 121, 11–18 (1995). · DOI
- Collombat, P. et al. Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression. J. Clin. Invest. 117, 961–970 (2007). · DOI
- Olbrot, M., Rud, J., Moss, L.G. & Sharma, A. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc. Natl. Acad. Sci. USA 99, 6737–6742 (2002). · DOI
- Matsuoka, T.A. et al. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol. Cell. Biol. 23, 6049–6062 (2003). · DOI
- Matsuoka, T.A. et al. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc. Natl. Acad. Sci. USA 101, 2930–2933 (2004). · DOI
- Nishimura, W. et al. A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev. Biol. 293, 526–539 (2006). · DOI
- Artner, I. et al. MafB: an activator of the glucagon gene expressed in developing islet alpha- and beta-cells. Diabetes 55, 297–304 (2006). · DOI
- Zhang, C. et al. MafA is a key regulator of glucose-stimulated insulin secretion. Mol. Cell. Biol. 25, 4969–4976 (2005). · DOI
- Wilson, M.E., Kalamaras, J.A. & German, M.S. Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas. Mech. Dev. 115, 171–176 (2002). · DOI
- Klimstra, D.S. in Histology for Pathologists. (ed. S.S. Sternberg) 613–647 (Lippincott-Raven Publishers, Philadelphia; 1997).
- Marzban, L. et al. Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Diabetes 55, 2192–2201 (2006). · DOI
- Okamoto, H. The role of poly(ADP-ribose) synthetase in the development of insulin-dependent diabetes and islet B-cell regeneration. Biomed. Biochim. Acta 44, 15–20 (1985).
- Eizirik, D.L. et al. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc. Natl. Acad. Sci. USA 91, 9253–9256 (1994). · DOI
- Hosokawa, M., Dolci, W. & Thorens, B. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin. Biochem. Biophys. Res. Commun. 289, 1114–1117 (2001). · DOI
- Yang, H. & Wright, J.R., Jr. Human beta cells are exceedingly resistant to streptozotocin in vivo. Endocrinology 143, 2491–2495 (2002). · DOI
- Hering, B.J. et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. J. Am. Med. Assoc. 293, 830–835 (2005). · DOI
- Zertal-Zidani, S., Bounacer, A. & Scharfmann, R. Regulation of pancreatic endocrine cell differentiation by sulphated proteoglycans. Diabetologia 50, 585–595 (2007). · DOI
- Attali, M. et al. Control of beta-cell differentiation by the pancreatic mesenchyme. Diabetes 56, 1248–1258 (2007). · DOI
- Tulachan, S.S. et al. All-trans retinoic acid induces differentiation of ducts and endocrine cells by mesenchymal/epithelial interactions in embryonic pancreas. Diabetes 52, 76–84 (2003). · DOI
- Kobayashi, H. et al. Retinoid signaling controls mouse pancreatic exocrine lineage selection through epithelial-mesenchymal interactions. Gastroenterology 123, 1331–1340 (2002). · DOI
- Tuch, B.E. & Monk, R.S. Regulation of blood glucose to human levels by human fetal pancreatic xenografts. Transplantation 51, 1156–1160 (1991). · DOI
- Tuch, B.E., Jones, A. & Turtle, J.R. Maturation of the response of human fetal pancreatic explants to glucose. Diabetologia 28, 28–31 (1985). · DOI
- Tuch, B.E. Reversal of diabetes by human fetal pancreas. Optimization of requirements in the hyperglycemic nude mouse. Transplantation 51, 557–562 (1991). · DOI
- Fornoni, A. et al. Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 51, 298–308 (2008). · DOI
- Weitgasser, R., Davalli, A.M. & Weir, G.C. Measurement of glucose concentrations in rats: differences between glucose meter and plasma laboratory results. Diabetologia 42, 256 (1999). · DOI
- Joannides, A. et al. Automated mechanical passaging: a novel and efficient method for human embryonic stem cell expansion. Stem Cells 24, 230–235 (2006). · DOI
- Schrot, R.J., Patel, K.T. & Foulis, P. Evaluation of inaccuracies in the measurement of glycemia in the laboratory, by glucose meters, and through measurement of hemoglobin A1c. Clin Diabetes 25, 43–49 (2007). · DOI
Cited by
Sorted by citations
Items 301–400 of 1,003
Regenerative medicine and cell-based approaches to restore pancreatic function
Ellis, C. E., Ramzy, A., & Kieffer, T. J. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.93 · Cited by 92
iPSC technology‐based regenerative therapy for diabetes
Kondo, Y., Toyoda, T., Inagaki, N., & Osafune, K. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12702 · Cited by 84
Growth factor control of pancreatic islet regeneration and function
Aßmann, A., Hinault, C., & Kulkarni, R. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00468.x · Cited by 72
“endocrine cells after implantation into mice (226).”
Long-Term Culture of Self-renewing Pancreatic Progenitors Derived from Human Pluripotent Stem Cells
Trott, J., Tan, E. K., Ong, S., Titmarsh, D. M., Denil, S. L. I. J., Giam, M., Wong, C. K., Wang, J., Shboul, M., Eio, M., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.019 · Cited by 77
“, 2013), thereby inspiring the development of protocols for the generation of pancreatic progenitors (Kroon et al., 2008) and subsequently b-like cells from human pluripotent stem cells (Pagliuca et al.”
BackgroundFowler, J. L., Ang, L. T., & Loh, K. M. (2019) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.368 · Cited by 87
“Prevailing strategies typically differentiate hPSC-derived endoderm into “primitive gut tube”, “posterior foregut,” and then “pancreatic progenitors” (Kroon et al., 2008; Pagliuca et al., 2014; Rezania et al., 2014) (Figure 2bi).”
BackgroundInfluentialDing, S., Kingshott, P., Thissen, H. W., Pera, M. F., & Wang, P. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26075 · Cited by 84
The role of hepatocyte nuclear factor 1β in disease and development
El-Khairi, R., & Vallier, L. (2016) · Diabetes, obesity and metabolism · doi:10.1111/dom.12715 · Cited by 76
The state of the art of islet transplantation and cell therapy in type 1 diabetes
Pellegrini, S., Cantarelli, E., Sordi, V., Nano, R., & Piemonti, L. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0847-z · Cited by 82
“Upon transplantation into immunocompromised mice, the graft (composed of endocrine and ductal cells) restored normoglycemia within 2 [66] or 6 weeks [67], a tremendous improvement compared with the 2- to 3-month period required after transplantation of ESCderived pancreatic progenitors [61].”
BackgroundStem Cell-based Tissue Engineering Approaches for Musculoskeletal Regeneration
Brown, P. T., Handorf, A. M., Jeon, W. B., & Li, W. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990350 · Cited by 75
Imparting regenerative capacity to limbs by progenitor cell transplantation
Lin, G., Chen, Y., & Slack, J. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.11.017 · Cited by 76
“For example, transplantation of muscle satellite cells has been shown to lead to functional recovery of dystrophic muscle (Zammit et al., 2006), and pancreatic precursors made from embryonic stem cells can cure diabetic animals (Kroon et al., 2008).”
BackgroundStem Cell Therapy for Diabetes: Beta Cells versus Pancreatic Progenitors
Memon, B., & Abdelalim, E. M. (2020) · Cells · doi:10.3390/cells9020283 · Cited by 75
“While the viability, and hence, developmental capacity of hPSC‐derived pancreatic progenitor, immune‐protected during the longer maturation period in vivo has been demonstrated in rodents [9,30,31], it is yet to be determined in humans.”
BackgroundRobert, T., Mesmaeker, I. D., Stangé, G. M., Suenens, K. G., Ling, Z., KROON, E. J., & PIPELEERS, D. G. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.01.040 · Cited by 79
“…be efficiently differentiated to pancreatic endoderm (D’Amour et al., 2005, 2006) that forms beta cells following implantation in immune-deficient mice (Kroon et al., 2008; Rezania et al., 2012) or following further in vitro steps (Pagliuca et al., 2014; Rezania et al., 2014; Russ et al., 2015).”
BackgroundMethodInfluentialSelf-citationZdravkovic, T., Nazor, K. L., Larocque, N., Gormley, M., Donne, M. L., Hunkapillar, N., Giritharan, G., Bernstein, H. S., Wei, G. H., Hebrok, M., et al. (2015) · Development · doi:10.1242/dev.122846 · Cited by 75
“In vitro differentiation followed the method of Kroon et al. (2008).”
MethodMembranes to achieve immunoprotection of transplanted islets
Schweicher, J. (2014) · Frontiers in bioscience · doi:10.2741/4195 · Cited by 94
“This retrievable and vascularizing capsule will contain pancreatic progenitor cells that are expected to differentiate into functioning islet cells(29-32, 110).”
BackgroundSmall-molecule inducers of insulin expression in pancreatic α-cells
Fomina‐Yadlin, D., Kubicek, S., Walpita, D., Dančík, V., Hecksher‐Sørensen, J., Bittker, J. A., Sharifnia, T., Shamji, A. F., Clemons, P. A., Wagner, B. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010018107 · Cited by 77
“An alternative approach, not yet feasible, is to create new β-cells (2), either by stepwise differentiation of undifferentiated stem or stem-like cells (3), or by transdifferentiation (4), the heritable change of cell identity to an insulin-producing (β-like) cell.”
BackgroundWu, F., Su, R., Lai, Y., & Wang, X. (2017) · eLife · doi:10.7554/elife.23702 · Cited by 74
“When AR/AL level increased from C1 to C2, the circuit’s quadrastability becomes well pronounced, illustrated as four similar-sized colored spheres on the same gray plane, which represents the low-low, GFP, mCherry, and high-high state, respectively (Figure 3—figure supplement 1).”
BackgroundMethodShahjalal, H. M., Shiraki, N., Sakano, D., Kikawa, K., Ogaki, S., Baba, H., Kume, K., & Kume, S. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju029 · Cited by 73
“Recently, it has been shown that hES cell-derived pancreatic endoderm cells that were transplanted into immunodeficient mice underwent further differentiation and maturation into glucose-responsive INS-secreting cells (Kroon et al., 2008; Rezania et al., 2012, 2013), suggesting that the pancreatic precursors obtained…”
BackgroundInfluentialGeneration of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells
Zhu, F., Zhang, P. B., Zhang, D. H., Sui, X. Y., Yin, M., Xiang, T. T., Shi, Y., Ding, M. X., & Deng, H. (2011) · Diabetologia · doi:10.1007/s00125-011-2246-x · Cited by 70
“Similarly, a previous study demonstrated that transplantation of hESCderived pancreatic endoderm in mice could generate insulin-producing cells in vivo [41].”
ResultBrehm, M., Bortell, R., Diiorio, P., Leif, J., Laning, J., Cuthbert, A., Yang, C.-X., Herlihy, M., Burzenski, L., Gott, B., et al. (2010) · Diabetes · doi:10.2337/db10-0323 · Cited by 74
“Diabetes 59:2265–2270, 2010 Investigators are working to develop functional human -cells from adult or embryonic stem cells (ESCs) or from induced pluripotent stem (iPS) cells (1–4), and human ESC-derived -cells can restore euglycemia in streptozotocin (STZ) diabetic immunodeficient mice (5).”
BackgroundBarreca, M. M., Cancemi, P., & Geraci, F. (2020) · Cells · doi:10.3390/cells9051163 · Cited by 83
“Some preclinical studies and clinical trials confirmed the potential of stem cell therapy in treating several diseases, such as diabetes mellitus [26,27], heart failure [28,29], disorders of the nervous system [30–32], and so on.”
BackgroundXu, K., Narayanan, K., Lee, F., Bae, K. H., Gao, S., & Kurisawa, M. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.06.026 · Cited by 77
Mfopou, J. K., Chen, B., Sui, L., Sermon, K., & Bouwens, L. (2010) · Diabetes · doi:10.2337/db10-0439 · Cited by 73
“Other studies made use of RA combined with FGF ligands (FGF4, FGF7, FGF10) or of Noggin combined with FGF2 and EGF to induce pancreatic cells albeit at a lower efficiency than for combined Noggin and RA (Table 3) (13,14,16,17,19,23).”
BackgroundInfluentialTranscription factor regulation of pancreatic organogenesis, differentiation and maturation
Dassaye, R., Naidoo, S., & Cerf, M. E. (2015) · Islets · doi:10.1080/19382014.2015.1075687 · Cited by 80
Bruin, J. E., Asadi, A., Fox, J., Erener, S., Rezania, A., & Kieffer, T. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.013 · Cited by 72
“Based largely on evidence from preclinical studies in immunodeficient mice (Kroon et al., 2008; Kelly et al., 2011; Rezania et al., 2012, 2013; Bruin et al., 2013; Motté et al., 2014), the safety of hESC-derived pancreatic progenitor cells is now being evaluated clinically in a small cohort of…”
BackgroundAre stem cells a cure for diabetes?
McCall, M., Toso, C., Baetge, E. E., & Shapiro, A. M. J. (2009) · Clinical Science · doi:10.1042/cs20090072 · Cited by 68
Self-citationStem cell sources to treat diabetes
Furth, M. E., & Atala, A. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22000 · Cited by 69
“An important recent report shows that when transplanted into mice, human ES-derived cells with a phenotype corresponding to pancreatic endoderm matured to yield cells capable of maintaining near-normal regulation of blood sugar [Kroon et al., 2008].”
BackgroundTreatment of Diabetes and Long-Term Survival After Insulin and Glucokinase Gene Therapy
Callejas, D., Mann, C. J., Ayuso, E., Lage, R., Grifoll, I., Roca, C., Andaluz, A., Fernández, R. R. D. G. I., Montané, J., MUÑOZ, S. A., et al. (2013) · Diabetes · doi:10.2337/db12-1113 · Cited by 78
Higuchi, Y., Shiraki, N., Yamane, K., Qin, Z., Mochitate, K., Araki, K., Senokuchi, T., Yamagata, K., Hara, M., Kume, K., et al. (2010) · Journal of Cell Science · doi:10.1242/jcs.066886 · Cited by 71
“Many researchers have reported differentiation procedures for pancreatic cell lineages from ES cells (Jiang et al., 2007; Kroon et al., 2008).”
BackgroundGenerating hepatic cell lineages from pluripotent stem cells for drug toxicity screening
Baxter, M. A., Rowe, C., Alder, J. E., Harrison, S. P., Hanley, K. P., Park, B. K., Kitteringham, N. R., Goldring, C. E., & Hanley, N. A. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.02.002 · Cited by 67
“Results showed that threemonths post-transplantation the implant contained glucose-responsive insulinsecreting cells that were functionally very similar to transplanted adult human islets (Kroon et al., 2008).”
Functions of p53 in pluripotent stem cells
Fu, X., Wu, S., Li, B., Xu, Y., & Liu, J. (2019) · Protein & Cell · doi:10.1007/s13238-019-00665-x · Cited by 80
Preserving Mafa Expression in Diabetic Islet β-Cells Improves Glycemic Control in Vivo
Matsuoka, T., Kaneto, H., Kawashima, S., Miyatsuka, T., Tochino, Y., Yoshikawa, A., Imagawa, A., Miyazaki, J., GANNON, M. A., Stein, R. W., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.595579 · Cited by 69
“Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan, the ¶Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6303, and the Department of Molecular Physiology & Biophysics, Vanderbilt University Medical School, Nashville, Tenne…”
BackgroundInfluentialRevealing transcription factors during human pancreatic β cell development
Conrad, E., Stein, R. W., & Hunter, C. S. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.03.013 · Cited by 68
Directing Lung Endoderm Differentiation in Pluripotent Stem Cells
Kadzik, R. S., & Morrisey, E. E. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.03.013 · Cited by 69
Generation of functional insulin-producing cells in the gut by Foxo1 ablation
Talchai, S. C., Xuan, S., Kitamura, T., DePinho, R. A., & Accili, D. (2012) · Nature Genetics · doi:10.1038/ng.2215 · Cited by 173
“Regulated insulin secretion is a critical feature of pancreatic β -cells that has proved difficult to replicate in ES cell-derived insulin-producing cells 2 .”
Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors
Hiratsuka, M., Uno, N., Ueda, K., Kurosaki, H., Imaoka, N., Kazuki, K., Ueno, E., Akakura, Y., Katoh, M., Osaki, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025961 · Cited by 70
“In addition, iPS cells should have a safeguard system because iPS cells with teratoma-forming potential can persist even after differentiation, leading to unexpected and undesired events [16].”
BackgroundGuney, M. A., & Gannon, M. (2009) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20156 · Cited by 70
“Transplantation of immature cells under the kidney capsule allows for completion of the β cell differentiation pathway in vivo from these stem cell-like progenitors (Kroon et al., 2008).”
BackgroundKang, H., Kim, J., Park, S., Kim, J.-Y., Kim, H., Kim, K. S., Lee, E. J., Seo, S., Kang, S., Lee, J., et al. (2009) · Stem Cells · doi:10.1002/stem.127 · Cited by 70
Mastracci, T. L., Anderson, K. R., Papizan, J. B., & Sussel, L. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003278 · Cited by 69
“sources for beta cell replacement therapies [1,2,3].”
Expanding the Boundaries of Embryonic Stem Cells
Ben‐David, U., Kopper, O., & Benvenisty, N. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.003 · Cited by 69
“Comparison of the mouse and human pluripotent networks revealed, quite surprisingly, that species-specific transposable elements have considerably altered the transcriptional pluripotent circuitry, so that in each species the same core factors bind a distinct set of TF-binding sites and play distinct roles in pluripot…”
BackgroundGraham, M. L., Bellin, M. D., Papas, K. K., Hering, B. J., & Schuurman, H. (2011) · Xenotransplantation · doi:10.1111/j.1399-3089.2011.00676.x · Cited by 77
“These conclusions are not unequivocal as hypoglycemia might also have arisen from the absent first-phase insulin release mentioned earlier and/or reduced counter-regulatory responses [48].”
BackgroundSilva, I. B. B., Kimura, C. H., Colantoni, V. P., & Sogayar, M. C. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02977-y · Cited by 99
Stem-cell based organ-on-a-chip models for diabetes research
Rogal, J., Zbinden, A., Schenke‐Layland, K., & Loskill, P. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.010 · Cited by 89
The Role of Microfluidics for Organ on Chip Simulations
Aziz, A. U. R., Geng, C., Fu, M., Yu, X., Qin, K., & Liu, B. (2017) · Bioengineering · doi:10.3390/bioengineering4020039 · Cited by 107
Tissue Engineering Approaches to Cell-Based Type 1 Diabetes Therapy
Amer, L. D., Mahoney, M. J., & Bryant, S. J. (2014) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2013.0462 · Cited by 64
“Implanted pancreatic precursor cells derived from hESCs without a scaffold have been shown to reverse hyperglycemia in nude mice, but take several weeks to have an effect.(28,29) Combining these cells with a scaffold may be able to shorten the maturation time needed to achieve functional implants.”
BackgroundEngineering the human pluripotent stem cell microenvironment to direct cell fate
Hazeltine, L. B., Selekman, J. A., & Palecek, S. P. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.03.002 · Cited by 66
“A later study employed a similar 4-step protocol to obtain pancreatic endoderm cells (Kroon et al., 2008).”
MethodCho, C. H., Hannan, N., Docherty, F. M., Docherty, H. M., Lima, M., Trotter, M., Docherty, K., & Vallier, L. (2012) · Diabetologia · doi:10.1007/s00125-012-2687-x · Cited by 68
“Current methods involve undefined animal products such as feeders, FBS and Matrigel and only allow for the generation of heterogeneous populations of cells, thus increasing the risk of teratoma formation after transplantation [7, 8].”
MethodConcise Review: Pancreas Regeneration: Recent Advances and Perspectives
Lysy, P. A., Weir, G. C., & Bonner‐Weir, S. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0025 · Cited by 71
Kim, D., Ryu, J., Son, M., Oh, J., Chung, K., Lee, S., Lee, J., Ahn, J., Min, J., Ahn, J., et al. (2017) · Hepatology · doi:10.1002/hep.29324 · Cited by 75
“These results support the notion that the generation of mature and functional differentiated cells from hPSC cultures is challenging for many cell types, such as hepatocytes, pancreatic endocrine cells, and cardiomyocytes.((38-40)) In this context, the development of adequate methodology necessary to assess the differ…”
ResultGage, B. K., Webber, T. D., & Kieffer, T. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082076 · Cited by 75
“patterning to endodermal gut tube [5,6], and retinoic acid”
BackgroundTranscriptional control of mammalian pancreas organogenesis
Cano, D. A., Soria, B., Martín, F., & Rojas, A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1510-2 · Cited by 67
Activin A and Wnt-dependent specification of human definitive endoderm cells.
Toivonen, S., Lundin, K., Balboa, D., Ustinov, J., Tamminen, K., Palgi, J., Trokovic, R., Tuuri, T., & Otonkoski, T. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.07.007 · Cited by 67
Lima, M., Muir, K. R., Docherty, H., Drummond, R., McGowan, N. W. A., Forbes, S., Heremans, Y., Houbracken, I., Ross, J., Forbes, S., et al. (2013) · Diabetes · doi:10.2337/db12-1256 · Cited by 67
Prabakar, K. R., Domínguez-Bendala, J., Molano, R., Pileggi, A., Villate, S., Ricordi, C., & Inverardi, L. (2012) · Cell Transplantation · doi:10.3727/096368911x612530 · Cited by 67
Chemical Strategies for Stem Cell Biology and Regenerative Medicine
Zhu, S., Wei, W., & Ding, S. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124715 · Cited by 66
“Through the application of knowledge learned from embryonic development, conditions have been developed to differentiate ESCs/iPSCs in a stepwise manner into desired cell populations (63), including dopamine neurons (64), retinal pigment epithelium (65), floor plate cells (66), hematopoietic cells (67), endothelial ce…”
BackgroundTalavera‐Adame, D., Wu, G. D., He, Y., Ng, T. T., Gupta, A., Kurtovic, S., Hwang, J. Y., Farkas, D. L., & Dafoe, D. C. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9232-z · Cited by 56
“Under the appropriate influences, ESCs are able to differentiate into insulin-producing cells [3–11].”
BackgroundStretching the limits: Stem cells in regeneration science
Stocum, D. L., & Zupanc, G. K. H. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21774 · Cited by 70
Weng, C., Xi, J., Li, H., Cui, J., Gu, A., Lai, S., Leskov, K., Ke, L., Jin, F., & Li, Y. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00314-2 · Cited by 65
Mitigating Ischemic Injury of Stem Cell-Derived Insulin-Producing Cells after Transplant
Faleo, G., Russ, H. A., Wisel, S., Parent, A. V., Nguyen, V., Nair, G. G., Freise, J. E., Villanueva, K. E., Szot, G. L., Hebrok, M., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.07.012 · Cited by 65
“The combined effect of cell death and de-differentiation may explain the inconsistent results with SCIPC grafts and the long duration needed to achieve graft function reported previously (Kroon et al., 2008; Matveyenko et al., 2010).”
BackgroundResultAddressing Stem Cell Therapeutic Approaches in Pathobiology of Diabetes and Its Complications
Peng, B., Dubey, N. K., Mishra, V. K., Tsai, F.-C., Dubey, R., Deng, W., & Wei, H.-J. (2018) · Journal of Diabetes Research · doi:10.1155/2018/7806435 · Cited by 82
“Human ESC (hESC) has been demonstrated to differentiate into functional β-cells in vivo [76].”
BackgroundhPSC-derived lung and intestinal organoids as models of human fetal tissue
Aurora, M., & Spence, J. R. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.06.006 · Cited by 69
“…organlike structures from hPSCs, including intestine, stomach, lung, kidney, brain and retina among others (D’Amour et al., 2006; Dye et al., 2015; Kroon et al., 2008; Lancaster et al., 2013; McCracken et al., 2014; Nakano et al., 2012; Si-Tayeb et al., 2010; Takasato et al., 2015; Wells and…”
BackgroundResultStem cell approaches for diabetes: towards beta cell replacement
Weir, G. C., Cavelti‐Weder, C., & Bonner‐Weir, S. (2011) · Genome Medicine · doi:10.1186/gm277 · Cited by 60
“Embryonic and induced pluripotent stem cells It has already been shown that human embryonic stem cells (ESCs) can be directed to become fully mature beta cells.”
BackgroundInfluentialConverting human pluripotent stem cells into β-cells: recent advances and future challenges
Mayhew, C. N., & Wells, J. M. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283337e1c · Cited by 60
Tiyaboonchai, A., Cardenas-Diaz, F. L., Ying, L., Maguire, J., Sim, X., Jobaliya, C. D., Gagne, A. L., Kishore, S., Stanescu, D. E., Hughes, N., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.12.026 · Cited by 64
“Virtually all differentiation protocols from either ES or EP cells utilize similar inductive signals at this stage including FGF, inhibition of sonic hedgehog, and RA signaling (Cheng et al., 2012; Kroon et al., 2008; Nostro et al., 2011; Rezania et al., 2013).”
Sui, L., Bouwens, L., & Mfopou, J. K. (2013) · International Journal of Developmental Biology · doi:10.1387/ijdb.120115ls · Cited by 64
Cell Delivery: From Cell Transplantation to Organ Engineering
Soto-Gutierrez, A., Yagi, H., Uygun, B., Navarro-Alvarez, N., Uygun, K., Kobayashi, N., Yang, Y.-G., & Yarmush, M. (2010) · Cell Transplantation · doi:10.3727/096368910x508753 · Cited by 64
Pancreatic islet transplantation: current advances and challenges
Wang, Q., Huang, Y., Liu, L., Zhao, X., Sun, Y., Mao, X., & Li, S.-W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1391504 · Cited by 63
Richardson, T., Barner, S., Candiello, J., Kumta, P. N., & Banerjee, I. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.02.025 · Cited by 66
Gao, X., Song, L., Shen, K., Wang, H., Qian, M., Niu, W., & Qin, X. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.03.004 · Cited by 73
“Heretofore, robust glucose-induced insulin secretion, the main function of b cell, has only been possible in hESC-derived cells after in vitro transplantation for several months (Kroon et al., 2008; D’Amour et al., 2006).”
BackgroundDeconstructing Pancreas Development to Reconstruct Human Islets from Pluripotent Stem Cells
McKnight, K. D., Wang, P., & Kim, S. K. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.03.003 · Cited by 62
“…optimism about the possibility that methods currently under development will produce cells resembling pancreatic or islet progenitors from pluripotent cells like human ESCs or iPSCs that can be used to replace b cells destroyed in T1DM (D’Amour et al., 2006; Kroon et al., 2008; Zhang et al., 2009).”
BackgroundMethodInfluentialAghazadeh, Y., Sarangi, F., Poon, F., Nkennor, B., McGaugh, E. C., Nunes, S. S., & Nostro, M. C. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.03.004 · Cited by 62
“These data indicate that in vivo , the NS-and Ft-derived PPs give rise to non-pancreatic tissues from multiple germ layers, characteristic of teratoma (Kroon et al., 2008).”
BackgroundInfluentialAdvances Toward Engineering Functionally Mature Human Pluripotent Stem Cell-Derived β Cells
Velazco-Cruz, L., Goedegebuure, M. M., & Millman, J. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00786 · Cited by 68
Cell Therapy for Type 1 Diabetes: Current and Future Strategies
Aghazadeh, Y., & Nostro, M. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0863-6 · Cited by 66
Development of an Encapsulated Stem Cell-Based Therapy for Diabetes
Tomei, A., Villa, C., & Ricordi, C. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1055242 · Cited by 62
“ES cells differentiated into PP (Figure 3) and transplanted into mice protected against streptozotocin-induced hyperglycemia and showed serum C-peptide that was comparable to 3000 IEQ human islets [127].”
Naujok, O., Diekmann, U., & Lenzen, S. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9509-0 · Cited by 62
“Different protocols were used to generate cells of the definitive endoderm germ layer and the primitive gut tube: classical induction of DE and primitive gut tubewas conducted as described earlier [9] using a sequential approach with 25 ng/ml wnt3a and 100 ng/ml activin A for one day, followed by a 2 day treatment wit…”
MethodHuman embryonic stem cell differentiation into insulin secreting β‐cells for diabetes
Bose, B., Shenoy, S., Konda, S., & Wangikar, P. (2012) · Cell Biology International · doi:10.1042/cbi20120210 · Cited by 62
“Modified pancreatic differentiation by Kroon et al. (2008) reported the production of insulin-producing cells from hESC which were also in vivo responsive to glucose.”
BackgroundGenerating pancreatic β-cells from embryonic stem cells by manipulating signaling pathways
Tsaniras, S. C., & Jones, P. M. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0073 · Cited by 54
“More recently, the Novocell group has applied their protocol to generate endocrine precursors in vitro, and then grafted these progenitors into diabetic mice to promote their full maturation (Kroon et al. 2008), generating cells that secreted insulin at levels comparable to mature b-cells.”
A high-throughput screen for teratogens using human pluripotent stem cells.
Kameoka, S., Babiarz, J., Kolaja, K., & Chiao, E. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kft239 · Cited by 62
Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?
Bourgeois, S., Sawatani, T., Mulders, A. V., Leu, N. D., Heremans, Y., Heimberg, H., Cnop, M., & Staels, W. (2021) · Cells · doi:10.3390/cells10010191 · Cited by 73
“An alternative approach seeks not to generate mature cells, but uses early definitive endoderm or pancreatic progenitor cells and relies strongly on self-directed differentiation and maturation in order to obtain a functional stem cell-derived beta cell mass in vivo [70,87,88].”
BackgroundHuman pluripotent stem cell-derived insulin-producing cells: A regenerative medicine perspective
Migliorini, A., Nostro, M. C., & Sneddon, J. B. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.021 · Cited by 62
Higuchi, A., Ling, Q., Kumar, S. S., Munusamy, M. A., Alarfaj, A. A., Umezawa, A., & Wu, G. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2014.01.002 · Cited by 75
Guo, T., Landsman, L., Li, N., & Hebrok, M. (2013) · Diabetes · doi:10.2337/db12-0167 · Cited by 62
“5, the time point of gene array analysis, we tested the effects of the combined mesenchymal factors on primitive gut tube cells generated via the standard protocol (factors were added after day 6 of the standard protocol) (10).”
BackgroundMethodInfluentialJuhl, K., Bonner‐Weir, S., & Sharma, A. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283344932 · Cited by 55
Human expandable pancreatic progenitor–derived β cells ameliorate diabetes
Ma, X., Lu, Y., Zhou, Z., Li, Q., Chen, X., Wang, W., Jin, Y., Hu, Z., Chen, G., Deng, Q., et al. (2022) · Science Advances · doi:10.1126/sciadv.abk1826 · Cited by 60
Matveyenko, A. V., Georgia, S., Bhushan, A., & Butler, P. C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00279.2010 · Cited by 59
“Several efforts have been reported with varying degrees of success (7, 10, 11, 13, 24).”
BackgroundMethodResultInfluentialRecent Development of Drug Delivery Systems through Microfluidics: From Synthesis to Evaluation
Ma, Z., Li, B.-C., Peng, J., & Gao, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020434 · Cited by 59
“studies, which reduces the usage of animal experiments and fills the gap between animal studies and clinical trials to some extent [81].”
BackgroundMethodSalg, G. A., Giese, N. A., Schenk, M., Hüttner, F. J., Felix, K., Probst, P., Diener, M. K., Hackert, T., & Kenngott, H. (2019) · Journal of Tissue Engineering · doi:10.1177/2041731419884708 · Cited by 76
Wang, P., Goodwill, P., Pandit, P., Gaudet, J., Ross, A. W., Wang, J., Yu, E. Y., Hensley, D., Doyle, T. C., Contag, C., et al. (2018) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2018.02.06 · Cited by 59
Development of Islet Organoids from H9 Human Embryonic Stem Cells in Biomimetic 3D Scaffolds
Wang, W.-W., Jin, S., & Ye, K.-M. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0115 · Cited by 59
“Furthermore, we added Noggin (an inhibitor of bone morphogenetic protein signaling), retinoic acid, and fi-broblast growth factor 7 (FGF7 or KGF) [34–37] sequentially to the cell culture media to differentiate DE cells into pancreatic progenitors.”
The Pharmacology of Regenerative Medicine
Christ, G. J., Saul, J. M., Furth, M. E., & Andersson, K. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007393 · Cited by 63
Capturing epidermal stemness for regenerative medicine
Barrandon, Y., Grasset, N., Zaffalon, A., Gorostidi, F., Claudinot, S., Droz-Georget, S. L., Nanba, D., & Rochat, A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.09.011 · Cited by 61
“[114] Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, et al.”
BackgroundUngrin, M. D., Clarke, G., Yin, T., Niebrugge, S., Nostro, M., Sarangi, F., Wood, G., Keller, G., & Zandstra, P. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.24375 · Cited by 59
Mimeault, M., & Batra, S. (2008) · Gut · doi:10.1136/gut.2008.150052 · Cited by 59
Teo, A., Valdez, I., Dirice, E., & Kulkarni, R. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.05.007 · Cited by 58
“Our DE-inducing conditions gave rise to pancreatic progenitor markers SOX9 and PDX1 comparably with Kroon et al. (2008) in two different hPSC lines (Figure S4B), demonstrating equivalence in terms of their differentiation potential.”
BackgroundMethodResultInfluentialPiccand, J., Meunier, A., Merle, C., Jia, Z.-P., Barnier, J., & Gradwohl, G. (2013) · Diabetes · doi:10.2337/db13-0384 · Cited by 58
Zebrafish Pancreas Development and Regeneration
Prince, V., Anderson, R. M., & Dalgin, G. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.10.005 · Cited by 64
“…these initial studies, many laboratories have published protocols that promote the production of insulin-expressing beta-like cells from stem cells (Bruin et al., 2013; D’Amour et al., 2006; Kroon et al., 2008; McGrath et al., 2015; Pagliuca et al., 2014; Rezania et al., 2013; Toyoda et al., 2015).”
BackgroundKim, J., Magli, A., Chan, S., Oliveira, V. K. P., Wu, J.-B., Darabi, R., Kyba, M., & Perlingeiro, R. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.04.022 · Cited by 57
“…a specific lineage (Tabar and Studer, 2014), with dozens of these applied to in vitro disease modeling, and many fewer to in vivo regeneration (Darabi et al., 2012; Hargus et al., 2010; Kriks et al., 2011; Kroon et al., 2008; Laflamme et al., 2007; Sebastiano et al., 2014; Wang et al., 2012).”
BackgroundMesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes
Figliuzzi, M. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i2.163 · Cited by 61
Chen, A. E., Borowiak, M., Sherwood, R. I., Kweudjeu, A., & Melton, D. (2013) · Development · doi:10.1242/dev.085431 · Cited by 57
“Although significant progress has been made in the derivation of β-like cells from ES (D’Amour et al., 2006; Jiang et al., 2007; Kroon et al., 2008; Micallef et al., 2012; Nostro et al., 2011; Zhang et al., 2009) and iPS (Maehr et al.”
Backgroundl -Leucine Alters Pancreatic β-Cell Differentiation and Function via the mTor Signaling Pathway
Rachdi, L., Aïello, V., Duvillié, B., & Scharfmann, R. (2011) · Diabetes · doi:10.2337/db11-0765 · Cited by 59
“Specifically, the signals and conditions that underlie the differentiation of embryonic stem cells into PDX-1–positive pancreatic progenitor cells are now well established (36,37).”
BackgroundDifferentiation of Human Embryonic Stem Cells Into Functional Ovarian Granulosa-like Cells
Lan, C.-W., Chen, M.-J., Jan, P.-S., Chen, H.-F., & Ho, H.-N. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4302 · Cited by 56
“Human embryonic stem cells (hESCs) have an unlimited capacity for self-renewal and can differentiate into most or all cell types that belong to the ectoderm (4), mesoderm (5), and endoderm (6).”
Background
Metadata
- Authors
- Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., Agulnick, A. D., D'Amour, K. A., Carpenter, M. K., & Baetge, E. E.
- Venue
- Nature Biotechnology
- Published
- 2008-02-20
- Volume
- 26
- Issue
- 4
- Pages
- 443-452
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2106219965
- Cited by
- 1,843
- References
- 0
- Citations by year
- 2026: 26 · 2025: 44 · 2024: 46 · 2023: 88 · 2022: 67 · 2021: 81 · 2020: 85 · 2019: 76 · 2018: 87 · 2017: 98 · 2016: 122 · 2015: 116 · 2014: 156 · 2013: 168 · 2012: 154
- FWCI
- 150.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- human embryonic stem cells, beta cell differentiation, glucose-dependent insulin secretion, islet transplantation, diabetes cell therapy, C-peptide, proinsulin processing, streptozotocin-induced hyperglycemia
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Endoderm, Glucose, Humans, Insulin, Cell Culture Techniques, Pancreas, Artificial, Tissue Engineering, Cell Proliferation, Insulin-Secreting Cells, Mice, Embryonic Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review